Paul Tudor Jones’s OptimizeRx OPRX Stock Holding History

Paul Tudor Jones’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,700	Closed	-$211K	–	2593
2022 Q2	$211K	Buy	+7,700	New	+$228K	0.01%	1784

Other funds holding OPRX

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Samjo Management New York $293M AUM 57.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Paul Tudor Jones's OPRX Position: Q3 2024 in Review

Paul Tudor Jones sold out of OptimizeRx (OPRX) in Q3 2024, closing a stake of 30,519 shares — an estimated $305K sold.

Paul Tudor Jones first reported a position in OPRX in Q1 2021 and held it in 10 quarters. The position peaked at $1.27M in Q2 2021. 85 funds tracked by Wall St. Rank hold OPRX as of Q3 2024.

Paul Tudor Jones reported no remaining OptimizeRx position as of Q3 2024 after selling out during the quarter.
Paul Tudor Jones sold 30,519 OptimizeRx shares in Q3 2024, an estimated $305K.
Paul Tudor Jones first reported a position in OptimizeRx in Q1 2021 and held it in 10 quarters.
Paul Tudor Jones's OptimizeRx position peaked at $1.27M in Q2 2021.
85 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2024.

Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.